Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
40.18
+0.14 (0.35%)
At close: Nov 12, 2024, 4:00 PM
40.49
+0.31 (0.77%)
Pre-market: Nov 13, 2024, 4:48 AM EST
Legend Biotech Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for Legend Biotech stock have an average target of 81.46, with a low estimate of 60 and a high estimate of 94. The average target predicts an increase of 102.74% from the current stock price of 40.18.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Legend Biotech stock from 13 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 5 | 5 | 6 | 6 |
| Buy | 7 | 8 | 7 | 7 | 7 | 7 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 13 | 12 | 12 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Reiterates $86 | Buy | Reiterates | $86 | +114.04% | Oct 29, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $73 | Strong Buy | Reiterates | $73 | +81.68% | Oct 16, 2024 |
| Redburn Atlantic | Redburn Atlantic | Strong Buy Initiates $86 | Strong Buy | Initiates | $86 | +114.04% | Oct 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $73 | Strong Buy | Reiterates | $73 | +81.68% | Oct 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $73 | Strong Buy | Reiterates | $73 | +81.68% | Sep 30, 2024 |
Financial Forecast
Revenue This Year
598.91M
from 285.14M
Increased by 110.04%
Revenue Next Year
1.06B
from 598.91M
Increased by 77.16%
EPS This Year
-1.09
from -2.94
EPS Next Year
-0.68
from -1.09
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 687.0M | 1.4B | 2.3B | ||
| Avg | 598.9M | 1.1B | 1.7B | ||
| Low | 454.6M | 824.6M | 1.2B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 140.9% | 129.9% | 115.4% | ||
| Avg | 110.0% | 77.2% | 56.6% | ||
| Low | 59.4% | 37.7% | 13.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.51 | 0.40 | 1.72 | ||
| Avg | -1.09 | -0.68 | 0.51 | ||
| Low | -1.68 | -1.60 | -0.04 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.